Mirabella Fabio, Murison Alexander, Aronson Lauren I, Wardell Christopher P, Thompson Andrew J, Hanrahan Sarah J, Fok Jacqueline H L, Pawlyn Charlotte, Kaiser Martin F, Walker Brian A, Davies Faith E, Morgan Gareth J
Centre for Myeloma Research, Division of Molecular Pathology, The Institute of Cancer Research, Sutton, United Kingdom.
Proteomics Core Facility, The Institute of Cancer Research, London, United Kingdom.
PLoS One. 2014 Jun 12;9(6):e99493. doi: 10.1371/journal.pone.0099493. eCollection 2014.
The chromosomal translocation t(4;14) deregulates MMSET (WHSC1/NSD2) expression and is a poor prognostic factor in multiple myeloma (MM). MMSET encodes two major protein isoforms. We have characterized the role of the shorter isoform (REIIBP) in myeloma cells and identified a clear and novel interaction of REIIBP with members of the SMN (survival of motor neuron) complex that directly affects the assembly of the spliceosomal ribonucleic particles. Using RNA-seq we show that REIIBP influences the RNA splicing pattern of the cell. This new discovery provides novel insights into the understanding of MM pathology, and potential new leads for therapeutic targeting.
染色体易位t(4;14)会使MMSET (WHSC1/NSD2) 的表达失调,是多发性骨髓瘤 (MM) 中的不良预后因素。MMSET编码两种主要的蛋白质异构体。我们已经阐明了较短异构体 (REIIBP) 在骨髓瘤细胞中的作用,并确定了REIIBP与运动神经元存活 (SMN) 复合体成员之间明确且新颖的相互作用,这种相互作用直接影响剪接体核糖核蛋白颗粒的组装。通过RNA测序,我们表明REIIBP会影响细胞的RNA剪接模式。这一新发现为理解MM病理学提供了新的见解,并为治疗靶点提供了潜在的新线索。